REEP4 Antibody

Code CSB-PA875682LA01HU
Size US$166
Order now
Image
  • Western blot
    All lanes: REEP4 antibody at 0.7μg/ml + U251 whole cell lysate
    Secondary
    Goat polyclonal to rabbit IgG at 1/10000 dilution
    Predicted band size: 30, 20 kDa
    Observed band size: 30 kDa

  • Immunohistochemistry of paraffin-embedded human adrenal gland tissue using CSB-PA875682LA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human testis tissue using CSB-PA875682LA01HU at dilution of 1:100

  • Immunofluorescent analysis of Hela cells using CSB-PA875682LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

  • Western Blot
    Positive WB detected in: U251 whole cell lysate, A549 whole cell lysate, MCF-7 whole cell lysate, PC-3 whole cell lysate, 293 whole cell lysate
    All lanes: REEP4 antibody at 1:1500
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 30, 20 kDa
    Observed band size: 30 kDa

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) REEP4 Polyclonal antibody
Uniprot No.
Target Names
REEP4
Alternative Names
REEP4; C8orf20; PP432; Receptor expression-enhancing protein 4
Raised in
Rabbit
Species Reactivity
Human
Immunogen
Recombinant Human Receptor expression-enhancing protein 4 protein (78-257AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The REEP4 Antibody (Product code: CSB-PA875682LA01HU) is Non-conjugated. For REEP4 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA875682LB01HU REEP4 Antibody, HRP conjugated ELISA
FITC CSB-PA875682LC01HU REEP4 Antibody, FITC conjugated
Biotin CSB-PA875682LD01HU REEP4 Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
IHC 1:20-1:200
IF 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Microtubule-binding protein required to ensure proper cell division and nuclear envelope reassembly by sequestering the endoplasmic reticulum away from chromosomes during mitosis. Probably acts by clearing the endoplasmic reticulum membrane from metaphase chromosomes.
Gene References into Functions
  1. Our results show that REEP3/4 function redundantly to clear the endoplasmic reticulum from metaphase chromatin, thereby ensuring correct progression through mitosis and proper nuclear envelope architecture. PMID: 23911198
Subcellular Location
Endoplasmic reticulum membrane; Multi-pass membrane protein.
Protein Families
DP1 family
Tissue Specificity
Expressed in circumvallate papillae and testis.
Database Links

HGNC: 26176

OMIM: 609349

KEGG: hsa:80346

STRING: 9606.ENSP00000303482

UniGene: Hs.289063

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*